HCAT (Health Catalyst, Inc.) Stock Financials & Earnings

HCATHealth Catalyst, Inc.

Mkt Cap$132M

Revenue (TTM)$316M

Net Income (TTM)-$108M

EPS (TTM)-$1.59

Free Cash Flow (TTM)-$23M

Gross Margin46.5%

Op. Margin-29.2%

Net Margin-34.1%

FCF Margin-7.2%

P/S Ratio (TTM)0.4x

P/E Ratio (TTM)—

YoY Rev Growth+4.6%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 12

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$69M	$31M	-$37M
Q1 23	$74M	$36M	-$35M
Q2 23	$73M	$34M	-$35M
Q3 23	$74M	$32M	-$25M
Q4 23	$75M	$31M	-$33M
Q1 24	$75M	$36M	-$23M
Q2 24	$76M	$36M	-$16M
Q3 24	$76M	$34M	-$14M
Q4 24	$80M	$35M	-$18M
Q1 25	$79M	$36M	-$20M
Q2 25	$81M	$38M	-$37M
Q3 25	$76M	$38M	-$18M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 22	$20M	$16M	$20M
Q1 23	$17M	$24M	$19M
Q2 23	$18M	$24M	$16M
Q3 23	$18M	$12M	$15M
Q4 23	$20M	$15M	$17M
Q1 24	$15M	$15M	$19M
Q2 24	$14M	$14M	$13M
Q3 24	$14M	$12M	$11M
Q4 24	$15M	$16M	$11M
Q1 25	$15M	$14M	$15M
Q2 25	$12M	$8M	$13M
Q3 25	$12M	$16M	$14M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$116M	$247M	$363M
Q1 23	$133M	$223M	$357M
Q2 23	$116M	$228M	$344M
Q3 23	$95M	$253M	$348M
Q4 23	$106M	$211M	$318M
Q1 24	$201M	$126M	$328M
Q2 24	$202M	$106M	$308M
Q3 24	$328M	$59M	$387M
Q4 24	$250M	$142M	$392M
Q1 25	$342M	$0	$342M
Q2 25	$51M	$47M	$97M
Q3 25	$40M	$51M	$92M

Shares Outstanding

Revenue Per Employee

Revenue / Employee